Editas Medicine, Inc.
EDITNasdaqCIK 1650664HealthcareFiscal year ends Dec 31
Reports and events: 192 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-12-1116:23 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-23-000034 |
| 2023-11-2216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001650664-23-000026 |
| 2023-11-0316:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001650664-23-000017 |
| 2023-11-0307:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-23-000014 |
| 2023-10-1016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001650664-23-000005 |
| 2023-08-0216:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-012936 |
| 2023-08-0207:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-012810 |
| 2023-06-1516:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-011141 |
| 2023-06-0906:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-010931 |
| 2023-06-0516:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-23-010811 |
| 2023-05-1716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-23-010139 |
| 2023-05-0516:16 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-008308 |
| 2023-05-0507:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-008190 |
| 2023-04-1816:30 ET | DEF 14A | Proxy statement | 0001104659-23-046732 |
| 2023-04-1317:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-23-005886 |
| 2023-03-1416:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-23-003731 |
| 2023-02-2216:30 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-001764 |
| 2023-02-2206:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-001684 |
| 2023-01-0908:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-23-000130 |
| 2022-12-0606:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-018383 |
| 2022-11-1707:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-018016 |
| 2022-11-0216:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016012 |
| 2022-11-0206:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-015898 |
| 2022-08-0316:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-011904 |
| 2022-08-0306:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-011740 |
| 2022-06-1316:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-22-009970 |
| 2022-05-0416:32 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-007066 |
| 2022-05-0407:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-006937 |
| 2022-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001104659-22-050341 |
| 2022-04-1407:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-22-005418 |
| 2022-02-2416:40 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-001950 |
| 2022-02-2406:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-001821 |
| 2022-02-0716:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-22-000862 |
| 2021-11-0907:31 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015161 |
| 2021-11-0807:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-014923 |
| 2021-10-2809:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-21-013688 |
| 2021-09-2909:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-012862 |
| 2021-09-0816:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-21-012312 |
| 2021-08-0507:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-010390 |
| 2021-08-0407:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-010084 |
| 2021-06-0816:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-21-008121 |
| 2021-05-1416:57 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-21-066941 |
| 2021-05-0607:31 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-006073 |
| 2021-05-0507:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-005794 |
| 2021-04-2016:15 ET | DEF 14A | Proxy statementPeriod 2021-06-03 | 0001104659-21-052527 |
| 2021-02-2607:31 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-001915 |
| 2021-02-2507:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-001723 |
| 2021-02-1916:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001558370-21-001289 |
| 2021-02-0808:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-013334 |
| 2021-01-2116:47 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-006336 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.